title: Sex hormone regulation of survivin gene expression.
abstract: Survivin (BIRC5) is a cell survival gene that is overexpressed in endometrial cancer and has been implicated to have a physiological role in normal endometrial function. To determine whether survivin gene expression is regulated by reproductive steroid hormones in the human endometrium, RNA was prepared from normal cycling women in the proliferative and secretory phases of the menstrual cycle. RNA was also isolated from 21 endometrial biopsies from premenopausal women at baseline and following 3 months of treatment with depot medroxyprogesterone acetate. Finally, RNA was isolated from endometrial biopsies from ten healthy postmenopausal women participating in a clinical trial of estrogen replacement therapy at baseline and following 6 months of treatment with conjugated equine estrogen. Quantitative RT-PCR analysis was used to determine survivin, insulin-like growth factor binding protein 1 (IGFBP1), Ki67, and IGF1 gene expression levels. Survivin gene expression was highest in the proliferative phase of the menstrual cycle and showed a statistically significant 4-fold increase in expression following chronic treatment with estrogens; this was strongly correlated with increased Ki67, a marker of proliferation. Survivin gene expression decreased 4.6-fold following chronic progestin treatment in the human endometrium. These data suggest that survivin transcript is regulated by estrogens and progestins in the disease-free human endometrium. The data also suggest that survivin transcript may be used as a biomarker of estrogen and progestin treatment efficacy, but validation studies must be conducted to support this conclusion.
authors.affiliation: Department of Integrative Biology and Pharmacology, University of Texas Health Science Center Houston, 6431 Fannin Street, MSB 5.132A, Houston, Texas 77030, USA.
authors.forename: Nancy H
authors.initials: NH
authors.lastname: Nabilsi
authors.forename: Russell R
authors.initials: RR
authors.lastname: Broaddus
authors.forename: Adrienne S
authors.initials: AS
authors.lastname: McCampbell
authors.forename: Karen H
authors.initials: KH
authors.lastname: Lu
authors.forename: Henry T
authors.initials: HT
authors.lastname: Lynch
authors.forename: Lee-May
authors.initials: LM
authors.lastname: Chen
authors.forename: David S
authors.initials: DS
authors.lastname: Loose
mesh_terms: D000328:Adult; D004717:Endometrium / Q000187:drug effects* / Q000378:metabolism*; D004967:Estrogens / Q000494:pharmacology*; D005260:Female; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins; D008869:Microtubule-Associated Proteins / Q000235:genetics / Q000378:metabolism*; D008875:Middle Aged; D017698:Postmenopause; D011372:Progestins / Q000494:pharmacology*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D000077022:Survivin; D046509:Tissue Culture Techniques
chemical_list: C107489:BIRC5 protein, human; D004967:Estrogens; D051034:Inhibitor of Apoptosis Proteins; D008869:Microtubule-Associated Proteins; D011372:Progestins; D012333:RNA, Messenger; D000077022:Survivin
references.citation: J Clin Endocrinol Metab. 2002 Jul;87(7):3452-9
references.pmid: 12107265
references.citation: Mol Hum Reprod. 2000 Nov;6(11):1013-8
references.pmid: 11044464
references.citation: Biol Reprod. 1995 Mar;52(3):609-15
references.pmid: 7756454
references.citation: J Huazhong Univ Sci Technolog Med Sci. 2002;22(2):118-20, 170
references.pmid: 12658750
references.citation: Ginekol Pol. 2000 Sep;71(9):1226-9
references.pmid: 11083009
references.citation: Hum Reprod Update. 2000 Sep-Oct;6(5):495-504
references.pmid: 11045880
references.citation: Clin Cancer Res. 2005 Dec 1;11(23):8258-64
references.pmid: 16322283
references.citation: Placenta. 2007 Jul;28(7):650-7
references.pmid: 17113145
references.citation: Clin Cancer Res. 2006 Nov 1;12(21):6373-8
references.pmid: 17085648
references.citation: Mod Pathol. 2009 May;22(5):699-708
references.pmid: 19287462
references.citation: Cancer Lett. 2000 Dec 8;161(1):63-71
references.pmid: 11078914
references.citation: Cancer Res. 2007 Aug 15;67(16):7746-55
references.pmid: 17699779
references.citation: J Clin Endocrinol Metab. 1991 May;72(5):1014-24
references.pmid: 1708779
references.citation: Am J Obstet Gynecol. 1975 May;122(2):262-3
references.pmid: 1155504
references.citation: DNA Cell Biol. 1994 Aug;13(8):829-37
references.pmid: 7520702
references.citation: Experientia. 1974 Sep 15;30(9):1101-2
references.pmid: 4413221
references.citation: Gynecol Endocrinol. 1998 Dec;12(6):399-406
references.pmid: 10065165
references.citation: Cancer Lett. 2002 Oct 8;184(1):105-16
references.pmid: 12104054
references.citation: Endocr Relat Cancer. 2009 Mar;16(1):113-22
references.pmid: 18852162
references.citation: Leuk Lymphoma. 2005 Nov;46(11):1605-1612
references.pmid: 16334487
references.citation: J Mol Med (Berl). 2007 Jan;85(1):23-38
references.pmid: 17066266
references.citation: Hum Reprod Update. 2004 Jan-Feb;10(1):29-38
references.pmid: 15005462
references.citation: Anticancer Res. 2005 Nov-Dec;25(6B):4313-8
references.pmid: 16309234
references.citation: Mol Cell Endocrinol. 2000 Jul 25;165(1-2):75-83
references.pmid: 10940486
references.citation: Acta Obstet Gynecol Scand. 2002 Feb;81(2):162-7
references.pmid: 11942908
references.citation: J Clin Endocrinol Metab. 1996 Nov;81(11):4144-7
references.pmid: 8923873
references.citation: Biol Reprod. 2008 Jan;78(1):127-33
references.pmid: 17881769
references.citation: Mol Hum Reprod. 2006 Jun;12(6):383-8
references.pmid: 16644787
references.citation: Growth Horm IGF Res. 2004 Dec;14(6):431-5
references.pmid: 15519250
references.citation: Mol Cell Endocrinol. 1994 Aug;104(1):39-46
references.pmid: 7529731
references.citation: Cancer Biol Ther. 2009 Nov;8(22):2126-35
references.pmid: 19755863
references.citation: Int J Gynecol Pathol. 2005 Jul;24(3):247-53
references.pmid: 15968200
references.citation: Mol Cancer Ther. 2006 May;5(5):1087-98
references.pmid: 16731740
references.citation: Curr Cancer Drug Targets. 2003 Apr;3(2):131-52
references.pmid: 12678716
references.citation: Acta Endocrinol Suppl (Copenh). 1972;166:137-44
references.pmid: 4627287
references.citation: Hum Reprod. 1994 Feb;9(2):259-66
references.pmid: 7517949
references.citation: Ginekol Pol. 2001 Dec;72(12A):1539-42
references.pmid: 11883311
references.citation: Mol Hum Reprod. 2000 Jun;6(6):529-34
references.pmid: 10825370
references.citation: J Clin Endocrinol Metab. 2003 May;88(5):2157-63
references.pmid: 12727970
references.citation: Biochem J. 1999 Dec 1;344 Pt 2:305-11
references.pmid: 10567210
references.citation: Mod Pathol. 2007 Oct;20(10):1045-54
references.pmid: 17673926
references.citation: Oncogene. 2009 May 14;28(19):2046-50
references.pmid: 19363521
references.citation: Cancer. 2006 Aug 15;107(4):746-56
references.pmid: 16826583
references.citation: Nat Med. 1997 Aug;3(8):917-21
references.pmid: 9256286